1 active not recruiting, 1 not yet recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Zuberitamab 1000mg: new trials by email Literature Review of Zuberitamab 1000mg trials Research Report on Zuberitamab 1000mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Efficacy of Zuberitamab Injection in Patients With Primary Membranous Nephropathy Zuberitamab 1000mg, Cyclosporine - Primary Membranous Nephropathy | Phase 3 | Not yet recruiting | BioRay Pharmaceutical Co., Ltd. | 150 | 2026-10-01 | 2026-09-21 |
| A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy Zuberitamab 600mg, Zuberitamab 1000mg, cyclosporine - Primary Membranous Nephropathy | Phase 2 | Active not recruiting | BioRay Pharmaceutical Co., Ltd. | 135 | 2024-11-13 | 2025-11-20 |
BioRay Pharmaceutical Co., Ltd. (2)
China (2)